CymitQuimica logo

CAS 475110-96-4

:

2-(Difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole

Description:
2-(Difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole is a chemical compound characterized by its complex structure, which includes a benzimidazole core and a triazine moiety. The presence of difluoromethyl groups suggests that it may exhibit unique electronic properties and reactivity due to the electronegative fluorine atoms. The morpholine groups contribute to its potential solubility and interaction with biological systems, making it of interest in pharmaceutical applications. This compound may possess specific biological activities, potentially acting as a herbicide or fungicide, given its structural features that are often associated with agrochemical properties. Its molecular weight, solubility, and stability under various conditions would be critical for its practical applications. Additionally, the compound's synthesis and purification methods would be essential for obtaining it in a usable form for research or industrial purposes. Safety data, including toxicity and environmental impact, would also be important considerations for handling and application.
Formula:C19H21F2N7O2
InChI:InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2
InChI key:InChIKey=HGVNLRPZOWWDKD-UHFFFAOYSA-N
SMILES:C(F)(F)C=1N(C=2C(N1)=CC=CC2)C=3N=C(N=C(N3)N4CCOCC4)N5CCOCC5
Synonyms:
  • 1H-Benzimidazole, 2-(difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-
  • 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine
  • 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine
  • 2-(Difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole
  • Tcmdc-137004
  • Zstk 474
  • Zstk474
  • 4,4′-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
  • ZSTK474

    CAS:
    Formula:C19H21F2N7O2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:417.4125

    Ref: IN-DA00DB7V

    10mg
    91.00€
    50mg
    128.00€
  • 4,4'-(6-(2-(Difluoromethyl)-1H-Benzo[D]Imidazol-1-Yl)-1,3,5-Triazine-2,4-Diyl)Dimorpholine

    CAS:
    <p>4,4'-(6-(2-(Difluoromethyl)-1H-Benzo[D]Imidazol-1-Yl)-1,3,5-Triazine-2,4-Diyl)Dimorpholine</p>
    Purity:98%
    Molecular weight:417.41g/mol

    Ref: 54-PC108908

    1g
    516.00€
    5g
    1,573.00€
    100mg
    131.00€
    250mg
    206.00€
  • ZSTK474

    CAS:
    ZSTK474
    Purity:≥98%
    Molecular weight:417.41g/mol

    Ref: 54-BUP15432

    5mg
    51.00€
    10mg
    72.00€
    25mg
    95.00€
    50mg
    109.00€
    100mg
    149.00€
    200mg
    204.00€
  • Ref: 7W-GW6410

    1mg
    150.00€
    5mg
    193.00€
    10mg
    205.00€
  • ZSTK474

    CAS:
    <p>PI3K Inhibitor ZSTK474 is an orally available, s-triazine derivative, ATP-competitive phosphatidylinositol 3-kinase (PI3K) inhibitor with potential</p>
    Formula:C19H21F2N7O2
    Purity:98.29% - 99.95%
    Color and Shape:White Powder
    Molecular weight:417.41
  • ZSTK474

    CAS:
    Purity:99.0%
    Color and Shape:Solid
    Molecular weight:417.421

    Ref: 10-F050801

    250mg
    To inquire
  • ZSTK 474

    Controlled Product
    CAS:
    <p>Applications ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase (PI3K) isoforms. Potent PI3K inhibitor.<br>References Yaguchi, S., et al.: J. Natl. Cancer Inst., 98, 545 (2006); Kong, D., et al.: Cancer Sci., 98, 1638 (2007); Kong, D., et al.: Eur. J. Cancer, 45, 857 (2009); Marone, R., et al.: Mol. Cancer Res., 7, 601 (2009); Yang, S., et al.: PLoS One, 6, e26343 (2011); Haruta, K., et al.: Inflamm, Res., 61, 551 (2012);<br></p>
    Formula:C19H21F2N7O2
    Color and Shape:Neat
    Molecular weight:417.41

    Ref: TR-Z701000

    5mg
    89.00€
    10mg
    106.00€
    50mg
    360.00€
  • ZSTK474

    CAS:
    <p>ZSTK474 is a novel compound that has been shown to have autophagy-inducing properties. Studies have found that ZSTK474 inhibits the growth of human cancer cells in vitro and in vivo, and also has inhibitory effects on epithelial mesenchymal transition (EMT) and metastasis. ZSTK474 targets the mitochondrial membrane potential and ATP production, which reduces cellular energy metabolism. These inhibitory effects lead to increased autophagy in cells, which may be due to the inhibition of protein synthesis and cell cycle progression. ZSTK474 has also been shown to induce apoptosis in cancer cells by inducing DNA damage.</p>
    Formula:C19H21O2N7F2
    Purity:Min. 95%
    Molecular weight:417.17248

    Ref: 3D-FD34127

    10mg
    303.00€
    25mg
    419.00€
    50mg
    596.00€